Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC5A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DEFB106B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
OTUB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PHF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PUS7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ME2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGARP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGFOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FYTTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM117B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on